Skip to main content
. 2014 Apr 28;13(7):1625–1643. doi: 10.1074/mcp.O113.034918

Fig. 2.

Fig. 2.

A global database providing a quality index for antibodies and comprehensive information about the validation process will be the first stop for researchers performing the RPPA technology.

HHS Vulnerability Disclosure